ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Metastases to lymph nodes | 16.22.02.006; 01.09.01.015 | 0.000278% | | Not Available |
Metastases to skin | 16.22.02.023; 23.07.04.026 | 0.000533% | | Not Available |
Monocytopenia | 01.02.02.005 | 0.000533% | | Not Available |
Pancreatic carcinoma metastatic | 16.13.10.003; 07.21.09.006 | 0.005004% | | Not Available |
Porokeratosis | 23.01.01.008; 03.05.01.021 | 0.000533% | | Not Available |
Purulent discharge | 11.01.08.061; 08.01.03.076 | 0.000533% | | Not Available |
Scleroderma-like reaction | 23.03.02.019; 15.06.01.018; 10.04.07.005 | 0.001066% | | Not Available |
Terminal state | 08.01.03.079 | 0.000533% | | Not Available |
Periarticular disorder | 15.01.08.014 | 0.001865% | | Not Available |
Metastases to meninges | 17.02.10.012; 16.22.02.003 | 0.000208% | | Not Available |
Clostridium difficile infection | 11.02.02.009 | - | - | Not Available |
Breast cancer metastatic | 21.05.01.016; 16.10.01.008 | 0.002432% | | Not Available |
Biliary dilatation | 09.02.03.004 | 0.000139% | | Not Available |
Cell death | 14.11.02.005; 08.03.03.003 | 0.001066% | | Not Available |
Metastatic carcinoma of the bladder | 16.08.01.004; 20.03.04.006 | 0.000139% | | Not Available |
General physical condition abnormal | 13.15.01.040 | 0.000533% | | Not Available |
Non-small cell lung cancer metastatic | 22.08.01.021; 16.19.01.009 | 0.000556% | | Not Available |
Escherichia infection | 11.02.10.004 | 0.000533% | | Not Available |
Foot deformity | 15.10.03.005 | 0.000799% | | Not Available |
Biliary tract infection | 11.01.18.003; 09.02.01.004 | 0.000533% | | |
Foaming at mouth | 17.02.05.056; 08.01.03.070; 07.05.05.019 | 0.000799% | | Not Available |
Acute left ventricular failure | 02.05.02.005 | 0.000139% | | Not Available |
Tryptase increased | 13.06.03.013 | 0.000533% | | Not Available |
Metastatic gastric cancer | 16.13.03.004; 07.21.02.004 | 0.000208% | | Not Available |
Onychalgia | 23.02.05.026 | 0.001066% | | Not Available |
Superinfection bacterial | 11.02.01.050 | 0.000799% | | Not Available |
Oral mucosal erythema | 07.05.05.023 | 0.001066% | | Not Available |
Neurosensory hypoacusis | 04.02.01.015; 17.04.07.007 | 0.000139% | | Not Available |
Skin plaque | 23.03.03.044 | 0.000533% | | Not Available |
Decreased eye contact | 17.02.05.055; 19.01.02.012 | 0.001066% | | Not Available |